Current therapy of patients with endometrial carcinoma.
Strahlenther Onkol 188(2012):12–20
| zurück | offene Studien: Endometrium-Karzinom | ||
| allgemeines | |||
| Operation | - | ||
| RT post OP | - | ||
| RCh post OP | RTOG 1070 | GOG-0249/endorsed study: A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma | CKTO-2006-04 | Phase III Randomized Study of Concurrent Chemoradiotherapy Followed By Adjuvant Chemotherapy Versus Pelvic Radiotherapy Alone in Patients With High-Risk Stage IB–III Endometrial Carcinoma | GOG 249 | Phase III Randomized Study of Pelvic Radiotherapy Versus Vaginal Cuff Brachytherapy, Paclitaxel, and Carboplatin in Patients with High-Risk Stage I or II Endometrial Carcinoma | GOG 258 | Phase III Randomized Study of Adjuvant Chemoradiotherapy Comprising Cisplatin and Tumor Volume-Directed Radiotherapy Followed by Carboplatin and Paclitaxel Versus Carboplatin and Paclitaxel Alone in Patients with Stage I–IVA Endometrial Carcinoma | RTOG 1073 | GOG-0258/endorsed study: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma |
| primäre RCh | - | ||
| primäre Chemotherapie | - | ||
| Histologie | - | ||
| Quellen |
1.) Marnitz S, Köhler C.: Current therapy of patients with endometrial carcinoma. Strahlenther Onkol 188(2012):12–20 | ||
|
|||
Impressum .....................................................................................Zuletzt geändert am 27.09.2012 6:23